Ondansetron ODT Tablets — Class II drug recall D-0239-2026
Ongoing recall by Preferred Pharmaceuticals, Inc., reported 2025-12-24. Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blis
| Recall number | D-0239-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2025-11-17 |
| Classified | 2025-12-17 |
| Reported by FDA | 2025-12-24 |
| Quantity | 575 |
| Reason classes | packaging |
| NDC | 68788-8666-01 |
| Lot numbers | I1725P, J1325J |
| Expiration dates | 2027-04-30 |
Product
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Reason for recall
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0239-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.